Valproic acid


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000085 Mitotic g2 phase Decreases phenotype PMID:23527032
GO:0000226 Microtubule cytoskeleton organization Decreases phenotype PMID:33823148
GO:0000724 Double-strand break repair via homologous recombination Increases phenotype PMID:24913804
GO:0000737 Dna catabolic process, endonucleolytic Increases phenotype PMID:24812151
GO:0001678 Cellular glucose homeostasis Affects phenotype PMID:38296531
GO:0001755 Neural crest cell migration Decreases phenotype PMID:26238599
GO:0001893 Maternal placenta development Decreases phenotype PMID:32437819
GO:0002523 Leukocyte migration involved in inflammatory response Increases phenotype PMID:24812151; PMID:34420476
GO:0002539 Prostaglandin production involved in inflammatory response Increases phenotype PMID:33823148
GO:0003810 Protein-glutamine gamma-glutamyltransferase activity Decreases phenotype PMID:34420476
GO:0004032 Alditol:nadp+ 1-oxidoreductase activity Increases phenotype PMID:25504687
GO:0004035 Alkaline phosphatase activity Increases phenotype PMID:25304967
GO:0004053 Arginase activity Increases phenotype PMID:34309930
GO:0004063 Aryldialkylphosphatase activity Decreases phenotype PMID:32662911
GO:0004089 Carbonate dehydratase activity Decreases phenotype PMID:34309930
GO:0004364 Glutathione transferase activity Decreases phenotype PMID:25304967; PMID:25504687; PMID:32662911
GO:0004396 Hexokinase activity Decreases phenotype PMID:28266800
GO:0004402 Histone acetyltransferase activity Decreases phenotype PMID:27381264
GO:0004407 Histone deacetylase activity Decreases phenotype PMID:33770205
GO:0004457 Lactate dehydrogenase activity Increases phenotype PMID:34309930; PMID:34309959
GO:0004602 Glutathione peroxidase activity Affects phenotype PMID:25504687; PMID:28988495; PMID:31760073; PMID:32662911; PMID:34309930; PMID:34309959; PMID:34420476
GO:0004784 Superoxide dismutase activity Decreases phenotype PMID:25504687; PMID:28988495; PMID:34309930; PMID:34309959; PMID:34420476; PMID:35090963
GO:0005249 Voltage-gated potassium channel activity Decreases phenotype PMID:26348896
GO:0005391 P-type sodium:potassium-exchanging transporter activity Decreases phenotype PMID:32662911
GO:0006054 N-acetylneuraminate metabolic process Affects phenotype PMID:25304967
GO:0006099 Tricarboxylic acid cycle Decreases phenotype PMID:24442146
GO:0006304 Dna modification Increases phenotype PMID:30404997
GO:0006306 Dna methylation Affects phenotype PMID:28853863
GO:0006309 Apoptotic dna fragmentation Affects phenotype PMID:19060243; PMID:22814014
GO:0006536 Glutamate metabolic process Affects phenotype PMID:37357844
GO:0006629 Lipid metabolic process Affects phenotype PMID:35156134
GO:0006641 Triglyceride metabolic process Affects phenotype PMID:33007364; PMID:33007364; PMID:39147356; PMID:33901630; PMID:34778935; PMID:39147356; PMID:39423997
GO:0006749 Glutathione metabolic process Increases phenotype PMID:25504687; PMID:26921665; PMID:29968957; PMID:30273971; PMID:32662911; PMID:32662911; PMID:34309959; PMID:33007364; PMID:34309930; PMID:34309959; PMID:37357844
GO:0006750 Glutathione biosynthetic process Affects phenotype PMID:30426164
GO:0006754 Atp biosynthetic process Decreases phenotype PMID:25716160
GO:0006776 Vitamin a metabolic process Affects phenotype PMID:35594946
GO:0006805 Xenobiotic metabolic process Affects phenotype PMID:25745819
GO:0006811 Monoatomic ion transport Increases phenotype PMID:2167745
GO:0006874 Cellular calcium ion homeostasis Affects phenotype PMID:34748853; PMID:35156134
GO:0006879 Cellular iron ion homeostasis Affects phenotype PMID:39147356
GO:0006915 Apoptotic process Affects phenotype PMID:11281642; PMID:17653085; PMID:19006566; PMID:19060243; PMID:19351772; PMID:21067264; PMID:21737646; PMID:24812151; PMID:25130820; PMID:26865186; PMID:29225137; PMID:32167238; PMID:34658283
GO:0006935 Chemotaxis Decreases phenotype PMID:29845424
GO:0006954 Inflammatory response Increases phenotype PMID:17994530
GO:0006974 Cellular response to dna damage stimulus Increases phenotype PMID:29845424
GO:0006979 Response to oxidative stress Affects phenotype PMID:19006566; PMID:19351772; PMID:20679181
GO:0007049 Cell cycle Decreases phenotype PMID:17653085; PMID:19351772; PMID:21737646
GO:0007204 Positive regulation of cytosolic calcium ion concentration Increases phenotype PMID:28762043
GO:0007625 Grooming behavior Decreases phenotype PMID:35254616; PMID:37207798
GO:0007631 Feeding behavior Affects phenotype PMID:31085223
GO:0008137 Nadh dehydrogenase (ubiquinone) activity Decreases phenotype PMID:31760073
GO:0008177 Succinate dehydrogenase (ubiquinone) activity Decreases phenotype PMID:31760073
GO:0008203 Cholesterol metabolic process Affects phenotype PMID:33007364; PMID:33007364; PMID:39147356; PMID:39147356
GO:0008217 Regulation of blood pressure Decreases phenotype PMID:20679181
GO:0008219 Cell death Increases phenotype PMID:17184924; PMID:17479365; PMID:22131109; PMID:26378038
GO:0008283 Cell population proliferation Increases phenotype PMID:17351657; PMID:17994530; PMID:19099629; PMID:25130820; PMID:19351772; PMID:19440698; PMID:20646843; PMID:21067264; PMID:21737646; PMID:23562654; PMID:25130820; PMID:25137620; PMID:31711903; PMID:33991534; PMID:34420476
GO:0008284 Positive regulation of cell population proliferation Affects phenotype PMID:25815518
GO:0008285 Negative regulation of cell population proliferation Increases phenotype PMID:22580532; PMID:32949729; PMID:34537371; PMID:34742744; PMID:37210002
GO:0008344 Adult locomotory behavior Decreases phenotype PMID:29778792
GO:0008610 Lipid biosynthetic process Increases phenotype PMID:25716160; PMID:27089845; PMID:30426164
GO:0008611 Ether lipid biosynthetic process Decreases phenotype PMID:29877216
GO:0008652 Amino acid biosynthetic process Decreases phenotype PMID:24442146
GO:0009060 Aerobic respiration Decreases phenotype PMID:25745980
GO:0009100 Glycoprotein metabolic process Affects phenotype PMID:34309930
GO:0009410 Response to xenobiotic stimulus Increases phenotype PMID:34537371
GO:0009448 Gamma-aminobutyric acid metabolic process Affects phenotype PMID:37357844
GO:0009636 Response to toxic substance Affects phenotype PMID:23179753
GO:0010508 Positive regulation of autophagy Increases phenotype PMID:25446377
GO:0010884 Positive regulation of lipid storage Increases phenotype PMID:28762043
GO:0010918 Positive regulation of mitochondrial membrane potential Affects phenotype PMID:25446377; PMID:25745980; PMID:28762043
GO:0010940 Positive regulation of necrotic cell death Increases phenotype PMID:35543257
GO:0010942 Positive regulation of cell death Increases phenotype PMID:22580532; PMID:25446377; PMID:25745980; PMID:27015953; PMID:28001369; PMID:28762043
GO:0010977 Negative regulation of neuron projection development Increases phenotype PMID:29261810; PMID:30578912
GO:0014045 Establishment of endothelial blood-brain barrier Decreases phenotype PMID:32240654
GO:0016042 Lipid catabolic process Increases phenotype PMID:28988495; PMID:31760073; PMID:32662911; PMID:33007364; PMID:34309930
GO:0016049 Cell growth Decreases phenotype PMID:23562654; PMID:25091725; PMID:29225137; PMID:29845424; PMID:30426164
GO:0016477 Cell migration Decreases phenotype PMID:29845424; PMID:34658283
GO:0016505 Peptidase activator activity involved in apoptotic process Increases phenotype PMID:24913804
GO:0016525 Negative regulation of angiogenesis Increases phenotype PMID:37207908
GO:0018158 Protein oxidation Increases phenotype PMID:31760073; PMID:32662911; PMID:32662911; PMID:34309959; PMID:34309930; PMID:34309959
GO:0019226 Transmission of nerve impulse Increases phenotype PMID:26348896
GO:0019432 Triglyceride biosynthetic process Increases phenotype PMID:30003287
GO:0021542 Dentate gyrus development Affects phenotype PMID:33150595
GO:0030154 Cell differentiation Increases phenotype PMID:23562654; PMID:31711903
GO:0030182 Neuron differentiation Decreases phenotype PMID:22131109; PMID:29775723
GO:0030199 Collagen fibril organization Increases phenotype PMID:24812151; PMID:34309930
GO:0030263 Apoptotic chromosome condensation Increases phenotype PMID:29225137
GO:0030308 Negative regulation of cell growth Increases phenotype PMID:37210002
GO:0031987 Locomotion involved in locomotory behavior Increases phenotype PMID:31760073; PMID:37357844
GO:0032000 Positive regulation of fatty acid beta-oxidation Decreases phenotype PMID:24442146
GO:0032922 Circadian regulation of gene expression Increases phenotype PMID:29229235
GO:0032930 Positive regulation of superoxide anion generation Increases phenotype PMID:28762043
GO:0034440 Lipid oxidation Increases phenotype PMID:25304967; PMID:25504687; PMID:29968957; PMID:30273971; PMID:37357844
GO:0035176 Social behavior Decreases phenotype PMID:29427782; PMID:29510222; PMID:30404997; PMID:32526256; PMID:35594946; PMID:37357844; PMID:29510222; PMID:32526256; PMID:35254616; PMID:35594946; PMID:36535311; PMID:37207798; PMID:37357844
GO:0035640 Exploration behavior Decreases phenotype PMID:32526256; PMID:35594946; PMID:35594946
GO:0035733 Hepatic stellate cell activation Increases phenotype PMID:24812151
GO:0035815 Positive regulation of renal sodium excretion Increases phenotype PMID:28693025
GO:0035936 Testosterone secretion Decreases phenotype PMID:37505509
GO:0036268 Swimming Decreases phenotype PMID:29427782
GO:0036444 Calcium import into the mitochondrion Increases phenotype PMID:31760073
GO:0040018 Positive regulation of multicellular organism growth Decreases phenotype PMID:29427782; PMID:32437819
GO:0042116 Macrophage activation Increases phenotype PMID:28184907
GO:0042129 Regulation of t cell proliferation Affects phenotype PMID:35090963
GO:0042267 Natural killer cell mediated cytotoxicity Increases phenotype PMID:32060585
GO:0042307 Positive regulation of protein import into nucleus Decreases phenotype PMID:24154490
GO:0042554 Superoxide anion generation Affects phenotype PMID:30426164
GO:0042572 Retinol metabolic process Affects phenotype PMID:32526256
GO:0042756 Drinking behavior Affects phenotype PMID:31085223
GO:0042919 Benzoate transport Decreases phenotype PMID:8140053
GO:0043005 Neuron projection Decreases phenotype PMID:37210002
GO:0043065 Positive regulation of apoptotic process Increases phenotype PMID:25815518; PMID:28762043; PMID:34742744
GO:0043966 Histone h3 acetylation Affects phenotype PMID:22711276; PMID:22723015; PMID:23378038; PMID:24200999; PMID:25769527; PMID:25815518; PMID:27237783; PMID:28743636; PMID:29225137; PMID:29778792; PMID:29845424; PMID:30897286
GO:0043967 Histone h4 acetylation Affects phenotype PMID:24200999; PMID:25769527; PMID:26378038; PMID:29778792; PMID:29845424
GO:0044237 Cellular metabolic process Decreases phenotype PMID:32167238; PMID:32623605; PMID:33007364; PMID:33901630; PMID:34658283; PMID:34748853; PMID:38296531
GO:0045176 Apical protein localization Decreases phenotype PMID:31368504
GO:0045333 Cellular respiration Decreases phenotype PMID:32623605
GO:0045429 Positive regulation of nitric oxide biosynthetic process Increases phenotype PMID:30273971
GO:0045651 Positive regulation of macrophage differentiation Increases phenotype PMID:28184907
GO:0045665 Negative regulation of neuron differentiation Increases phenotype PMID:29261810
GO:0045930 Negative regulation of mitotic cell cycle Increases phenotype PMID:22580532; PMID:29845424
GO:0046034 Atp metabolic process Affects phenotype PMID:32949729; PMID:35090963
GO:0046209 Nitric oxide metabolic process Affects phenotype PMID:28988495; PMID:32662911; PMID:34309930
GO:0046323 Glucose import Increases phenotype PMID:38296531
GO:0046330 Positive regulation of jnk cascade Increases phenotype PMID:23378038
GO:0046415 Urate metabolic process Decreases phenotype PMID:29968957
GO:0046449 Creatinine metabolic process Decreases phenotype PMID:17994530; PMID:29968957
GO:0046466 Membrane lipid catabolic process Increases phenotype PMID:35543257
GO:0047833 D-sorbitol dehydrogenase (acceptor) activity Increases phenotype PMID:25504687
GO:0048021 Regulation of melanin biosynthetic process Affects phenotype PMID:23001511
GO:0048060 Negative gravitaxis Decreases phenotype PMID:29427782
GO:0048266 Behavioral response to pain Decreases phenotype PMID:37357844
GO:0048312 Intracellular distribution of mitochondria Affects phenotype PMID:25446377
GO:0048386 Positive regulation of retinoic acid receptor signaling pathway Decreases phenotype PMID:27693483
GO:0048666 Neuron development Decreases phenotype PMID:35254616
GO:0048672 Positive regulation of collateral sprouting Increases phenotype PMID:23378038
GO:0048863 Stem cell differentiation Decreases phenotype PMID:25393219; PMID:32205227
GO:0048872 Homeostasis of number of cells Affects phenotype PMID:23527032
GO:0050729 Positive regulation of inflammatory response Increases phenotype PMID:35543257
GO:0050767 Regulation of neurogenesis Affects phenotype PMID:23527032
GO:0050768 Negative regulation of neurogenesis Affects phenotype PMID:24896083
GO:0050885 Neuromuscular process controlling balance Affects phenotype PMID:37357844
GO:0051149 Positive regulation of muscle cell differentiation Affects phenotype PMID:24896083
GO:0051402 Neuron apoptotic process Increases phenotype PMID:37357844
GO:0051881 Regulation of mitochondrial membrane potential Decreases phenotype PMID:19060243; PMID:27089845; PMID:30426164; PMID:31760073
GO:0051897 Positive regulation of protein kinase b signaling Decreases phenotype PMID:25453207
GO:0051938 L-glutamate import Affects phenotype PMID:29778792
GO:0055007 Cardiac muscle cell differentiation Decreases phenotype PMID:31445079
GO:0055072 Iron ion homeostasis Affects phenotype PMID:39147356
GO:0055074 Calcium ion homeostasis Affects phenotype PMID:30426164
GO:0055078 Sodium ion homeostasis Increases phenotype PMID:28693025
GO:0060135 Maternal process involved in female pregnancy Decreases phenotype PMID:32437819
GO:0060322 Head development Affects phenotype PMID:28635121
GO:0060326 Cell chemotaxis Decreases phenotype PMID:34658283
GO:0061029 Eyelid development in camera-type eye Decreases phenotype PMID:29427782
GO:0061518 Microglial cell proliferation Increases phenotype PMID:33823148
GO:0061744 Motor behavior Affects phenotype PMID:33991534
GO:0061890 Positive regulation of astrocyte activation Increases phenotype PMID:33823148
GO:0070265 Necrotic cell death Increases phenotype PMID:17994530; PMID:34420476; PMID:24812151; PMID:34420476
GO:0070368 Positive regulation of hepatocyte differentiation Increases phenotype PMID:25084468
GO:0070577 Lysine-acetylated histone binding Increases phenotype PMID:28743636
GO:0070633 Transepithelial transport Decreases phenotype PMID:8140053
GO:0070932 Histone h3 deacetylation Decreases phenotype PMID:29229235
GO:0070933 Histone h4 deacetylation Decreases phenotype PMID:29229235
GO:0070994 Detection of oxidative stress Increases phenotype PMID:24486436; PMID:35090963; PMID:39147356
GO:0072593 Reactive oxygen species metabolic process Affects phenotype PMID:32167238; PMID:33007364; PMID:34309930; PMID:34309959; PMID:34748853; PMID:35156134
GO:0090326 Positive regulation of locomotion involved in locomotory behavior Decreases phenotype PMID:28610743
GO:0090398 Cellular senescence Increases phenotype PMID:21067264
GO:0090557 Establishment of endothelial intestinal barrier Decreases phenotype PMID:32240654
GO:0090648 Response to environmental enrichment Decreases phenotype PMID:30404997
GO:0099610 Action potential initiation Decreases phenotype PMID:36375636
GO:0140042 Lipid droplet formation Increases phenotype PMID:33007364; PMID:33007364; PMID:39147356; PMID:33901630; PMID:33901630; PMID:39147356; PMID:37046073; PMID:39147356
GO:0140059 Dendrite arborization Decreases phenotype PMID:33991534
GO:0140253 Cell-cell fusion Increases phenotype PMID:37385477
GO:1900017 Positive regulation of cytokine production involved in inflammatory response Increases phenotype PMID:32240654
GO:1900111 Positive regulation of histone h3-k9 dimethylation Decreases phenotype PMID:25815518
GO:1900535 Palmitic acid biosynthetic process Increases phenotype PMID:30003287
GO:1900745 Positive regulation of p38mapk cascade Increases phenotype PMID:23378038
GO:1901216 Positive regulation of neuron death Increases phenotype PMID:24896083; PMID:33823148
GO:1901670 Negative regulation of superoxide dismutase activity Increases phenotype PMID:30273971
GO:1901726 Negative regulation of histone deacetylase activity Increases phenotype PMID:24896083; PMID:27693483
GO:1903409 Reactive oxygen species biosynthetic process Increases phenotype PMID:27089845; PMID:27381264; PMID:30426164; PMID:31760073
GO:1903428 Positive regulation of reactive oxygen species biosynthetic process Affects phenotype PMID:25745980; PMID:28762043
GO:1903980 Positive regulation of microglial cell activation Increases phenotype PMID:30404997; PMID:31369746
GO:1904105 Positive regulation of convergent extension involved in gastrulation Decreases phenotype PMID:27693483
GO:1904447 Folate import across plasma membrane Increases phenotype PMID:29223574
GO:1904456 Negative regulation of neuronal action potential Increases phenotype PMID:29596924
GO:1904846 Negative regulation of establishment of bipolar cell polarity Decreases phenotype PMID:31368504
GO:1990138 Neuron projection extension Increases phenotype PMID:23378038
GO:1990911 Response to psychosocial stress Decreases phenotype PMID:33823148
GO:1990962 Xenobiotic transport across blood-brain barrier Decreases phenotype PMID:2117062
GO:2000292 Regulation of defecation Affects phenotype PMID:32526256
GO:2000616 Negative regulation of histone h3-k9 acetylation Increases phenotype PMID:36535311
GO:2000617 Positive regulation of histone h3-k9 acetylation Increases phenotype PMID:28184907
GO:2000726 Negative regulation of cardiac muscle cell differentiation Increases phenotype PMID:34537371
GO:2000736 Regulation of stem cell differentiation Affects phenotype PMID:25247782
GO:2000987 Positive regulation of behavioral fear response Increases phenotype PMID:31369746
GO:2001170 Negative regulation of atp biosynthetic process Increases phenotype PMID:29501571; PMID:33147516
GO:2001171 Positive regulation of atp biosynthetic process Decreases phenotype PMID:26921665

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.